Porton was awarded as 2014 annual innovative advanced enterprise-Latest News and Updates from PORTON

Drug Modalities
- Small Molecules CDMO Services
- Tides CDMO Services
- Biologics and Conjugates CDMO Services
- Advanced Therapy Medicinal
  Products CRO & CDMO Services
Technical Solutions
- Crystallization
- Bio Catalysis
- Metal Catalysis
- Flow Chemistry
- Prep-Chromatography
- Milling
- Chemical Engineering and Technologies
ESG
- ESG
- ESG Concept
- ESG Policies
- ESG Reports
Newsroom
- Case Studies & Whitepapers
- Events
- News
- Marketing Collateral
About Us
- About Us
- Global Presence
- Corporate Governance
- Investors
- Digital Transformation
- Career
Contact Us

News 2015-04-02

Porton was awarded as 2014 annual innovative advanced enterprise

Porton was awarded as 2014 annual innovative advanced enterprise issued by the management committee of Changshou economic and technological development zone.

Others

News 2025-04-16

Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy

April 12, 2025 - Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD’s Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) (Approval No.: 2025LP01030). This breakthrough CAR-T therapy is indicated for recurrent glioblastoma (GBM).

News 2025-04-11

Porton Newsletter - March 2025 Recap

Technical Enabling Services & Solutions Company Events ESG Marketing Activities

Become part of Porton' s community to access personalized insights and resources.

First name *

Last name *

E-mail *

Company *

Subscribe To Our Mailing List

Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review ourLegal Disclaimer terms and Porton Privacy.

US: (609) 860-1300
CN: (86) 23-8608-3200

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton' s community to access personalized insights and resources.

Submit

By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

US: (609) 860-1300
CN: (86) 23-8608-3200